Cobra is a Contract Development and Manufacturing Organisation (CDMO) supporting the global life sciences industry in the development and manufacture of plasmid DNA and viral vectors for clinical trials and commercial supply.


Over 20 years of track record in producing biologics and pharmaceuticals for use in pre-clinical to Phase III clinical trials and commercial supply has given our people a unique knowledge base as both manufacturer and also as service providers for the global life sciences market.

We offer a broad range of integrated and stand-alone development services, bespoke to individual customer requirements, stretching from cell line and strain development to the supply of investigational medicinal product for clinical trials and commercial market supply.


Every program complies with GMP standards worldwide and is conceived with an unmatched quality derived from the know-how of Cobra’s highly qualified, flexible and dedicated people.

Our Centre of Excellence for Advanced Therapies based in the UK specialises in plasmid DNA and viral vector production.

Cobra takes pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.

Our Locations